FY4/25 1Q
Supplementary Materials

September 4, 2024

１．Consolidated Results■Year-on-Year(¥ million)

FY4/24 1Q
results

FY4/25 1Q
results

Net sales

94,654

103,603+8,949+9.5

Gross profit

13,19912,931(268)(2.0)% of net sales

13.9

12.5

9,588

10,174+586

+6.1

10.1

9.8

3,6102,757(853)(23.6)

3.8

2.7

3,881

2,969(912)(23.5)

4.1

2.9

2,140

1,642(498)(23.3)% of net sales

2.3

1.6

Earnings pershare(¥)

60.93

46.93

(14.00)(23.0)

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

YoYchange

YoYchange(%)

Figures in the table are rounded down

■Vs Plan(¥ million)

FY4/25 1Q
plan

FY4/25 1Q
results

Net sales

97,850103,603+5,753+5.9

Gross profit

12,642

12,931+289+2.3% of net sales

12.9

12.5

10,191

10,174(17)

(0.2)

10.4

9.8

2,451

2,757+306

+12.5

2.5

2.7

2,631

2,969+338+12.8

2.7

2.9

1,404

1,642+238+17.0% of net sales

1.4

1.6

Earnings pershare(¥)

40.12

46.93+6.81+17.0

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Profit attributableto owners of parent

Figures in the table are rounded down

-1-Vs planchangeVs planchange(%)

２. Segment Information（Dispensing Pharmacy Business）■Year-on-Year(¥ million)

FY4/24 1Q
results

FY4/25 1Q
results

Net sales

84,40591,866+7,461+8.8

Gross profit

9,349

8,464(885)(9.5)% of net sales

11.1

9.2

4,150

4,423+273+6.6

4.9

4.8

5,198

4,041(1,157)(22.3)

6.2

4.4

5,429

4,245(1,184)(21.8)

6.4

4.6

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

YoYchange

YoYchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income■Vs Plan(¥ million)

FY4/25 1Q
plan

FY4/25 1Q
results

Net sales

86,67091,866+5,196+6.0

Gross profit

8,360

8,464+104+1.2% of net sales

9.6

9.2

4,240

4,423

+183

+4.3

4.9

4.8

4,120

4,041(79)

(1.9)

4.8

4.4

4,270

4,245(25)

(0.6)

4.9

4.6

SG&A expenses% of net sales

Operating profit% of net sales

Segment profit% of net sales

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income-2-3. Segment Information（Cosmetic and Drug Store Business）■Year-on-Year(¥ million)

FY4/24 1Q
results

FY4/25 1Q
results

Net sales

7,412

8,947+1,535+20.7

Gross profit

2,855

3,474+619+21.7% of net sales

38.5

38.8

2,1492,467+318+14.8% of net sales

29.0

27.6

Operating profit

706

1,006+300+42.5% of net sales

9.5

11.2

Segment profit

710

1,016+306+43.1% of net sales

9.6

11.4

SG&A expenses

YoYchange

YoYchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income■Vs Plan(¥ million)

FY4/25 1Qplan

FY4/25 1Qresults

Net sales

8,290

8,947+657+7.9

Gross profit

3,190

3,474+284+8.9% of net sales

38.5

38.8

2,3602,467+107+4.5% of net sales

28.5

27.6

Operating profit

830

1,006+176+21.2% of net sales

10.0

11.2

Segment profit

830

1,016+186+22.4% of net sales

10.0

11.4

SG&A expenses

Vs planchange

Vs planchange(%)

Figures in the table are rounded down
Segment profit is adjusted to ordinary profit shown on the quarterly consolidated statement of income-3-4. Sales Verification■Dispensing Pharmacy Business (YoY）■Dispensing Pharmacy Business（Vs Plan）

Net sales

Net sales（%）

Average
Prescription
prescription
volume（%）
price

Average
Prescription
prescription
volumeprice

Same store (1,183)+6.0+1.9+4.0

Same store (1,183)+6.3（0.3)+6.5

Store openings in theprevious year (39)+908.4+642.6+35.7

Store openings in theprevious year (39)

+4.3

(0.2)

+4.4

+8.8+4.4＋4.3

Total (1,235)+6.0(0.4)+6.4

Total (1,235)■Cosmetic and Drug Store Business（YoY）■Cosmetic and Drug Store Business (Vs Plan）Net sales

Net sales（%）
Same store (74)Store openings in theprevious year (6)Total (82)

+14.8

Average
Number ofspending per
customers
customer（%）

Average
Number ofspending per
customers
customer+7.9+6.4

Same store (74)+8.7(0.4)+9.1+2,705.7 +2,335.4+15.2

Store openings in theprevious year (6)+2.4(0.4)+2.8

Total (82)+7.9（0.6)

+8.6

+20.7

+14.1

+5.8

-4-

5. Consolidated Balance Sheet■Assets(¥ million)

End-FY4/24 1Q

End-FY4/24

End-FY4/25 1Q

Change47,37312,719
24,340101,400
23,336
10,481

48,611
15,852
24,645
110,743
27,122
10,20749,404
13,88626,329109,359
27,625
10,158+793(1,966)+1,684(1,384)+503(49)

40,11343,45044,096+646

45,611
51,613
2,791
5,974
24,95044,066
51,242
3,345
6,403
25,18643,02050,3803,515
6,214
25,474(1,046)
(862)
+170
(189)
+288

42,52043,97344,303+330

Total assets

134,246
235,647

138,666
249,409

138,780
248,139+114(1,270)Figures in the table are rounded down

Change: End-FY4/25 1Q compared with end-FY4/24

Cash on hand and in banks
Accounts receivable
Inventories
Total current assets
Buildings and structures, netLand
Total property, plant andequipment
Goodwill
Total intangible fixed assets
Investments in securities
Deferred tax assets
Deposits and guarantees
Total investments and otherassets
Total fixed assets

Capital expenditures (Purchases of property, plant and equipment and intangible fixed assets + Deposits and guarantees)
totaled ¥ 3,310 million■Liabilities and Net Assets

End-FY4/24 1Q

End-FY4/24

End-FY4/25 1Q

ChangeTotal liabilities and net assets

64,8593,648
97,8403,848
11,189109,029
21,89420,50485,996
126,394
126,617
235,647

65,506
3,467
103,232
3,227
10,765
113,998
21,894
20,131
95,257
134,847
135,411249,40970,484
3,385
103,608
2,479
10,176
113,784
21,894
20,131
94,073
133,765
134,354248,139+4,978
(82)
+376
(748)
(589)
(214)
‐
‐
(1,184)(1,082)(1,057)(1,270)Figures in the table are rounded down

Change: End-FY4/25 1Q compared with end-FY4/24(¥ million)
Accounts payableShort-term debt
Total current liabilities
Long-term debt
Total long-term liabilities
Total liabilities
Common stock
Capital surplus
Retained earnings
Total shareholders’ equity
Total net assets-5-6. FY4/25 Plan (Consolidated)(¥ million)

FY4/24
results

FY4/25initial plan

FY4/25
revised plan

YoYchange(%)

Vs initialplan change（%）

Net sales

399,824

415,000

453,500+13.4+9.3

Gross profit

59,522

59,671

76,200

+28.0

+27.7

14.9

14.4

16.8

39,09041,871

56,840

+45.4

+35.8

9.8

10.1

12.5

20,432

17,80019,360(5.2)

＋8.8

5.1

4.3

4.3

21,37718,50020,000(6.4)

＋8.1

5.3

4.5

4.4

Profit attributableto owners of parent

11,401

9,180

10,000(12.3)＋8.9% of net sales

2.9

2.2

2.2

Earnings pershare(¥)

324.64262.33285.68(12.0)＋8.9

Annual dividend (¥)

80.00

80.00

80.00

0.0

0.0

% of net sales

SG&A expenses% of net sales

Operating profit% of net sales

Ordinary profit% of net sales

Figures in the table are rounded down-6-7. Transition of Store Openings■Number of Store Openings in Dispensing Pharmacy Business
FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23 FY4/24

FY4/251QOrganic

27252314152527196M&A182

1113461424114

216Total

1,066

1,029

1,132

1,088

1,065

1,099

1,209

1,231

1,235

■Number of Store Openings in Cosmetic and Drug Store Business
FY4/17 FY4/18 FY4/19 FY4/20 FY4/21 FY4/22 FY4/23 FY4/24

FY4/251QOrganic

947151112862Total

524854636978788182

Inquiries related to this presentation should be addressed toAIN HOLDINGS INC.
Corporate Planning Division
TEL: +81-3-5333‐1812
https://www.ainj.co.jp/corporate/

This document may not be reproduced or distributed to any third party without
prior approval of AIN HOLDINGS INC. This document has been prepared for
information purpose only and does not form part of a solicitation to sell orpurchase any securities. Information contained herein may be changed orrevised without prior notice. This document may contain forecasting statements
as to future results of operations. No forecast statement can be guaranteed andactual results of operations may differ from those projected.

-7-